 6. Subjects who have had any anticancer treatment prior to entering the study and have not recovered to baseline except alopecia or Grade 1 AEs, or deemed irreversible from the effects of prior cancer therapy. AEs Grade 1 that are not considered a safety risk by the Sponsor and Investigator may be allowed upon agreement with both. 